PrimeRFP SCOUT · Federal Contract Recompete Brief

SPE2D825F0GB14568301522!pv PHARM BRANCH VENDOR CAGE 0u9u0 — Amerisourcebergen Drug Corp

Amerisourcebergen Drug Corp holds $19.3B across 1,357,999 federal awards, concentrated at Department of Defense (DOD). This PIID sits alongside 1 related award under parent SPE2DX22D0030. PoP ended May 21, 2025 — the usual 12–18 month planning window is closed; recompete action looks late or overdue.

Dla Troop Support

Awarding office

Amerisourcebergen Drug Corp

Recipient

May 21, 2025

PoP end

$957K

Obligated

$957K

Potential

325411

NAICS

6505

PSC

Watch this recompete

One email. No account. We ping you if the window moves.

Score my position vs Amerisourcebergen Drug Corp — $90

Contract facts

Federal

Contract numberSPE2D825F0GB1

Also listed asSPE2DX22D0030-SPE2D825F0GB1

AgencyDla Troop Support

Awarding officeDla Troop Support

Awarding agencyDepartment of Defense (DOD)

Funding agencyDepartment of Defense (DOD)

IncumbentAmerisourcebergen Drug Corp

CAGE1XUY5

UEIKABZK8W6PQT3

NAICS325411

No full NAICS 325411 intel page yet. Browse NAICS intelligence

PSC6505

Parent IDIQ / IDVSPE2DX22D0030

Place of performanceCONSHOHOCKEN PA

Pricing typeFirm Fixed Price

Extent competedFull And Open Competition

PoP startMay 20, 2025

PoP end (current)May 21, 2025

Obligated$957K

Current value$957K

Potential value$957K

4568301522!PV PHARM BRANCH, VENDOR, CAGE 0U9U0 is a federal award for Dla Troop Support held by Amerisourcebergen Drug Corp. Estimated value $957K ($957K obligated). Current period of performance ends May 21, 2025. Place of performance: CONSHOHOCKEN PA.

4568301522!PV PHARM BRANCH, VENDOR, CAGE 0U9U0

Recompete timing

Public

● Past PoP end (457 days ago)

Current PoP ended May 21, 2025 (457 days ago). The usual 12–18 month agency planning window is closed — recompete action looks late / overdue relative to a normal cycle. Watch for bridge orders, follow-ons, or a new solicitation.

Incumbent footprint

Public record

Amerisourcebergen Drug Corp — $19.3B obligated across 1,357,999 awards (firm-wide, all agencies) · lead buyer Department of Defense (DOD).

% of firm-wide obligated ($19.3B) · all agencies

Department of Defense (DOD)$19.3B · 100%Department of Health and Human Services (HHS)$7.6M · 0%Department of Veterans Affairs (VA)$5.9M · 0%Department of Justice (DOJ)$68K · 0%

Open full company profile →

Related awards

Same parent · incumbent

36C77026P0121

DROSPIRENONE

$321K

Sep 27, 2026

Query this award live in SCOUT via MCP — personalized scoring, watchlists, and capture workflow across the corpus. Learn about SCOUT MCP →

Frequently asked questions

What is contract SPE2D825F0GB1?

SPE2D825F0GB1 (4568301522!pv PHARM BRANCH VENDOR CAGE 0u9u0) is a Dla Troop Support award with a potential value of $957K, currently held by Amerisourcebergen Drug Corp. Figures are USASpending-sourced public-record facts plus SCOUT recompete analysis.

Which office awarded SPE2D825F0GB1?

Dla Troop Support awarded SPE2D825F0GB1 to Amerisourcebergen Drug Corp (potential $957K).

Who is the incumbent on SPE2D825F0GB1?

Amerisourcebergen Drug Corp is the incumbent with $19.3B across 1357999 related awards in SCOUT’s public footprint. The current period of performance ends May 21, 2025.

When does Amerisourcebergen Drug Corp’s SPE2D825F0GB1 come up for recompete?

SCOUT tracks a period-of-performance end of May 21, 2025. Actual solicitation timing can shift with extensions, bridges, or consolidations.

Data: Showing contracts ≥ $100K from federal procurement records (FPDS-NG, SAM.gov, and related repositories), normalized by PrimeRFP SCOUT. Each row keyed by Award ID (PIID); task orders appear as independent rows.

Data as of Aug 11, 2026 · refreshed monthlyLatest procurement action May 20, 2025